This purposeful conversation between the serotoninergic and central dopaminergic units has long been demonstrated in experiments with haloperidol, a D2 receptor antagonist that attenuates the psychotomimetic consequences of psilocybin [five].Widespread recreational use of those mushrooms, on the other hand, prompted point out and federal government